��������

Taeyoung Lee has a robust background in finance and pharmaceuticals, holding the position of 투자심사역 at SBI Investment since May 2020. Prior experience includes serving as a Pharma/Bio Analyst at KB Securities from October 2018 to May 2020 and working as an Analyst focused on Pharmaceuticals and Biotechnology at Meritz Securities Co., Ltd. from April 2016 to October 2018. Early career experiences include a role as a Medical Representative at Astellas Pharma and an internship at Seoul National University Hospital in the Children's Hospital. Taeyoung Lee obtained a Bachelor's degree in Pharmacy from 한양대학교 and a Bachelor's degree in Environmental Health from Korea University.